Sherbrooke Park Advisers LLC Axogen, Inc. Transaction History
Sherbrooke Park Advisers LLC
- $230 Billion
- Q2 2025
A detailed history of Sherbrooke Park Advisers LLC transactions in Axogen, Inc. stock. As of the latest transaction made, Sherbrooke Park Advisers LLC holds 12,241 shares of AXGN stock, worth $273,831. This represents 0.06% of its overall portfolio holdings.
Number of Shares
12,241Holding current value
$273,831% of portfolio
0.06%Shares
3 transactions
Others Institutions Holding AXGN
# of Institutions
177Shares Held
40.6MCall Options Held
69.1KPut Options Held
0-
First Light Asset Management, LLC Edina, MN4.53MShares$101 Million7.55% of portfolio
-
Black Rock Inc. New York, NY3.25MShares$72.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.73MShares$61.1 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.51MShares$56.2 Million0.0% of portfolio
-
Balyasny Asset Management LLC Chicago, IL1.93MShares$43.2 Million0.03% of portfolio
About Axogen, Inc.
- Ticker AXGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 42,283,700
- Market Cap $946M
- Description
- AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...